These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 29859935)

  • 1. Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A.
    Xue X; Wang X; Zhao Y; Hu R; Qin L
    Biochem Biophys Res Commun; 2018 Aug; 502(4):515-521. PubMed ID: 29859935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
    Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
    World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
    Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
    Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
    Fornari F; Milazzo M; Chieco P; Negrini M; Marasco E; Capranico G; Mantovani V; Marinello J; Sabbioni S; Callegari E; Cescon M; Ravaioli M; Croce CM; Bolondi L; Gramantieri L
    J Pathol; 2012 Jul; 227(3):275-85. PubMed ID: 22262409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.
    Xue X; Zhao Y; Wang X; Qin L; Hu R
    J Cell Biochem; 2019 Jan; 120(1):135-142. PubMed ID: 30238497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma.
    Li W; Ding X; Wang S; Xu L; Yin T; Han S; Geng J; Sun W
    J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
    Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
    [No Abstract]   [Full Text] [Related]  

  • 8. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.
    Xu Y; Lai Y; Cao L; Li Y; Chen G; Chen L; Weng H; Chen T; Wang L; Ye Y
    RNA Biol; 2021 Oct; 18(10):1408-1423. PubMed ID: 33206588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression.
    Ye J; Yao Y; Song Q; Li S; Hu Z; Yu Y; Hu C; Da X; Li H; Chen Q; Wang QK
    Sci Rep; 2016 Oct; 6():34034. PubMed ID: 27698442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
    Wang K; Liang Q; Wei L; Zhang W; Zhu P
    Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
    Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
    Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma.
    Shi M; Jiang Y; Yang L; Yan S; Wang YG; Lu XJ
    J Cell Biochem; 2018 Jun; 119(6):4711-4716. PubMed ID: 29278659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
    Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
    Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of long non-coding RNA insulin-like growth factor 2-antisense suppressed hepatocellular carcinoma cell proliferation and metastasis by regulating the microRNA-520h/cyclin-dependent kinase inhibitor 1A signaling pathway.
    Huang Z; Su G; Bi X; Zhang L; Xu Z; Wang G
    Bioengineered; 2021 Dec; 12(1):6952-6966. PubMed ID: 34516353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
    Qin J; Luo M; Qian H; Chen W
    Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
    Sohn W; Kim J; Kang SH; Yang SR; Cho JY; Cho HC; Shim SG; Paik YH
    Exp Mol Med; 2015 Sep; 47(9):e184. PubMed ID: 26380927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-1202 suppresses hepatocellular carcinoma cells migration and invasion by targeting cyclin dependent kinase 14.
    Du B; Zhang P; Tan Z; Xu J
    Biomed Pharmacother; 2017 Dec; 96():1246-1252. PubMed ID: 29217161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome-Mediated MiR-155 Transfer Contributes to Hepatocellular Carcinoma Cell Proliferation by Targeting PTEN.
    Sun JF; Zhang D; Gao CJ; Zhang YW; Dai QS
    Med Sci Monit Basic Res; 2019 Oct; 25():218-228. PubMed ID: 31645540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
    Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
    Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.